From an initial formation through clinical trials and into commercialization, our risk advisors identify and address your ever-changing risk and liability needs as a company in the life sciences sector.
For the past 30 years, Britton Gallagher has served as a trusted risk management and insurance broker for life sciences companies in all stages of development and understand the importance of reaching the final step of your exit.
We have extensive experience in developing innovative insurance solutions for clients in the pharmaceutical, medical device and biotechnology industries. Britton Gallagher serves clients with business operations in countries around the world, coordinating the placement of multiple coverages through our network of global partners.
Founded in 1997, Ganeden is at the forefront of probiotic research and product development. It is best known for the GanedenBC30 its patented, FDA GRAS probiotic ingredient found in more than 125 leading food and beverage products around the world. The unique stability of GanedenBC30 allows manufacturers to produce effective probiotic functional foods, beverages and companion animal products. Bill Misconish, Ganeden CFO, discusses the challenges of being a growing business in the life sciences sector, including supply chain capacity issues along with packaging disclosures and regulatory demands. He shares how Britton Gallagher has become a proactive and critical risk management partner, advising on operational and customer issues. The BG team monitors the industry, providing the Ganeden team with updates on trends and keeping up with the company's rapid growth to ensure new ventures or changes are covered.
Diagnostics & Personalized Medicine
Medical Devices & Implants
Clinical Trials Liability
Customized Property Insurance
Directors & Officers
Errors & Omissions Liability
Excess & Umbrella Liability
Global Clinical Trials
Supply Chain Interruption